Kaleidoscope

An often under-appreciated fact: when it comes to AI, not all data is equally amenable to applications of ML. In

Welcome back to another edition of 'A Kaleidoscope of People', a series of posts that showcases the incredible

Over the years at Kaleidoscope, we’ve noticed a quirk in biotech and pharma companies that often surprises people not

Happy 2024! Welcoming a new year is a wonderful opportunity to reflect on the past year of learnings and growth.

In biotech, your technical moat is key. But not all technical components are equally defensible. In this Kaleidoscope blog post,

A few weeks ago, Kaleidoscope hosted a panel discussion on effective leadership in biotech, at the CIC in Boston. We

Many of us at Kaleidoscope have spent a lot of time working with, investing in, or employed by biotechs. Through

We recently wrapped up a company offsite; Kaleidoscope is a remote team, so these in-person weeks are a great opportunity

Through our interactions with biotech founders and teams, something we’ve heard often at Kaleidoscope is how challenging fundraising can

Welcome back to another edition of 'A Kaleidoscope of People', a series of posts that will focus on